Founder and Managing Director of DEV
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Managing director, the Foundry Group
Founder, Gilt Groupe
Redefining Early Stage Investments is a quarterly, ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. These events will give early stage life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace.